This inventor holds 1 USPTO granted patent. Top assignee: Adocia. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Jeff Tonnar: Innovator in Injectable Insulin Solutions
Introduction
Jeff Tonnar is a notable inventor based in Lyon, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable insulin solutions. His innovative work focuses on improving the formulation and efficacy of insulin for diabetic patients.
Latest Patents
Jeff Tonnar holds a patent for an injectable solution at pH 7, which comprises at least one basal insulin whose isoelectric point (pI) is between 5.8 and 8.5. This composition is designed as an injectable aqueous solution with a pH range between 6.0 and 8.0. It includes a basal insulin and a dextran that is substituted by radicals carrying carboxylate charges and hydrophobic radicals. The single-dose formulations are particularly effective at a pH of between 7 and 7.8, incorporating both a basal insulin and a prandial insulin.
Career Highlights
Jeff Tonnar has established himself as a key figure in the pharmaceutical industry. His work at Adocia, a company known for its innovative approaches to diabetes treatment, has allowed him to focus on developing advanced insulin formulations. His patent reflects his commitment to enhancing the quality of life for individuals with diabetes.
Collaborations
Throughout his career, Jeff has collaborated with esteemed colleagues such as Gerard Soula and Alexandre Geissler. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Jeff Tonnar's contributions to the field of injectable insulin solutions demonstrate his dedication to improving diabetes care. His innovative patent and collaborative efforts highlight the importance of research and development in the pharmaceutical industry.